IDH1 and glioblastoma: We also observed a consistent trend with the glioblastoma cohort, namely, a low level of ALDOC expression in the unmethylated MGMT and IDH1 wild-type group (p < 0.0001, p < 0.0001, respectively) (Figure 2B).